Table 3.

Potentially damaging vaccination delays for each dose of each vaccine in children younger than 2 y according to the French immunization schedule.

		Most frequently cited delay if consensus (> 70%)			2nd most frequently cited delay in the absence of consensus
Vaccines		Delay 1	%	95% CI	Delay 2	%	95% CI	Potentially dangerous delay
DTaP-IPV/Hiba	1stdose	15 d	71.4	51.1–86.0	/			15 d
2nd dose		15 d	78.6	58.5–91.0	/			15 d
1st booster dose		1 month	52.5	36.3–68.2	2 months	42.9	25.0–62.6	2 months
PCVb	1st dose	15 d	60.7	40.7–77.9	7 d	32.1	16.6–52.4	15 d
2nd dose		15 d	85.7	66.4–95.3	/			15 d
booster dose		1 month	67.9	47.6–83.4	2 months	28.6	14.0–48.9	2 months
MMRc	1st dose	1 month	89.3	70.6–87.2	/			1 month
2nd dose		6 months	64.3	44.1–80.7	1 month	22.5	11.4–38.9	6 months
MenCd		1 month	82.8	63.5–93.5	/			1 month
HBVe		11 y	78.6	58.5–91.0	/			11 y

^adiphtheria tetanus acellular pertussis-inactivated polio vaccine-Haemophilus influenzae b vaccine;

^bpneumococcal conjugate vaccine;

^cMeasles-Mumps-Rubella vaccine;

^dmeningococcal C vaccine;

^ehepatitis B vaccine;

Percentages of vote by experts were rounded off to one decimal, with 95% confidence interval (95% CI)